David Pernock, President and CEO of Eagle since January 2017, brings a wealth of pharmaceutical and biotechnology experience to the Eagle leadership team. David previously served as a member of Eagle’s board from April 2015 through December 2016. His strategic focus and entrepreneurial spirit have contributed to the commercial success of many products throughout his distinguished career.
Before joining Eagle, David served as Chairman of the Board of Directors and CEO (2010-2017) of Fibrocell Science, Inc., a publicly traded autologous cell and gene therapy company. David previously held various positions at GlaxoSmithKline, most notably serving as Senior Vice President of the Pharmaceuticals, Vaccines (Biologics), Oncology, Acute Care, and HIV Divisions. He also served as President of Reliant Pharmaceuticals and as a Director of Martek Biosciences Corporation. David earned a Bachelor of Science in Business Administration from Arizona State University.
- Primary/Complementary Interactive Styles: Mastermind/Warrior
- Interactive Combination: The Adventurer
- In a film, he’d be played by: William Shatner as Captain James T. Kirk
- Common Leadership Characteristic: Inspiring visionary with a plan to achieve his goals
